FDA.reportPublic FDA data

golimumab 50 MG per 0.5 ML Auto-Injector

RxCUI
1653142
RxNorm name
golimumab 50 MG per 0.5 ML Auto-Injector
Display name
golimumab 50 MG per 0.5 ML Auto-Injector
Full name
golimumab 50 MG per 0.5 ML Auto-Injector
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:28

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125289Simponigolimumab351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SimponiGOLIMUMABJanssen Biotech, Inc.f86cb4a7-c358-4136-ae57-b32bda9bba002025-10-29Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1653142

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
f86cb4a7-c358-4136-ae57-b32bda9bba00golimumab 50 MG per 0.5 ML Auto-InjectorSY42These highlights do not include all the information needed to use SIMPONI safely and effectively. See full prescribing information for SIMPONI. SIMPONI ® (golimumab) injection, for subcutaneous use Initial U.S. Approval: 200920251029
f86cb4a7-c358-4136-ae57-b32bda9bba000.5 ML golimumab 100 MG/ML Auto-InjectorSCD42These highlights do not include all the information needed to use SIMPONI safely and effectively. See full prescribing information for SIMPONI. SIMPONI ® (golimumab) injection, for subcutaneous use Initial U.S. Approval: 200920251029
f86cb4a7-c358-4136-ae57-b32bda9bba00golimumab 50 MG in 0.5 ML Auto-InjectorPSN42These highlights do not include all the information needed to use SIMPONI safely and effectively. See full prescribing information for SIMPONI. SIMPONI ® (golimumab) injection, for subcutaneous use Initial U.S. Approval: 200920251029